B-cell Lymphoblastic Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2024-12-16
Clinical Trial Update: CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors [Phase 1, Phase 2]
A Phase 1/2 trial evaluating CD19 and CD22 bispecific CAR T cells for relapsed/refractory B-cell hematologic tumors, currently recruiting.